Arovella Therapeutics

Popular Searches:

Your Previous Searches:

Recently Visited Pages:

Home
Sparks
Equities
Equities
View All Equities
Equities by Sector

Consumer

Energy & Resources

Financials

Healthcare

Industrials

Investment Companies

Metals & Mining

Real Estate

TMT

GlobalData

MCap

GBP1,092m

Last close

GBP1.94

▲ 16.50 (9.30%)

Metals One

MCap

GBP4m

Last close

GBP0.01

▲ 0.18 (19.44%)

Solid State

MCap

GBP95m

Last close

GBP1.90

▲ −2.00 (−1.04%)
Sectors
Sectors
Thematics
Thematics
View All Thematics

Latest
Audiovisual
Audiovisual
View All Audiovisual

Latest

Events
About Edison
About Edison
About Edison

Careers

“Edison’s accessible and high-quality research gives us the opportunity to communicate an independent perspective of Tyman to a wide variety of potential stakeholders.”

Financial Director
Equity Research
Investor Relations
Contact us

Overview
Research
Thematics

Arovella Therapeutics is a biotechnology company focused on developing therapies to treat cancer and conditions that affect the central nervous system.